14-77751457-A-C

Variant summary

Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2

The NM_012245.3(SNW1):​c.192T>G​(p.Phe64Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)

Consequence

SNW1
NM_012245.3 missense

Scores

8
8
3

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.705
Variant links:
Genes affected
SNW1 (HGNC:16696): (SNW domain containing 1) This gene, a member of the SNW gene family, encodes a coactivator that enhances transcription from some Pol II promoters. This coactivator can bind to the ligand-binding domain of the vitamin D receptor and to retinoid receptors to enhance vitamin D-, retinoic acid-, estrogen-, and glucocorticoid-mediated gene expression. It can also function as a splicing factor by interacting with poly(A)-binding protein 2 to directly control the expression of muscle-specific genes at the transcriptional level. Finally, the protein may be involved in oncogenesis since it interacts with a region of SKI oncoproteins that is required for transforming activity. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
SLIRP (HGNC:20495): (SRA stem-loop interacting RNA binding protein) Steroid receptor RNA activator (SRA, or SRA1; MIM 603819) is a complex RNA molecule containing multiple stable stem-loop structures that functions in coactivation of nuclear receptors. SLIRP interacts with stem-loop structure-7 of SRA (STR7) and modulates nuclear receptor transactivation (Hatchell et al., 2006 [PubMed 16762838]).[supplied by OMIM, Mar 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
SNW1NM_012245.3 linkuse as main transcriptc.192T>G p.Phe64Leu missense_variant 3/14 ENST00000261531.12 NP_036377.1 Q13573
SNW1NM_001318844.2 linkuse as main transcriptc.192T>G p.Phe64Leu missense_variant 3/13 NP_001305773.1 G3V3A4
SNW1XM_047431112.1 linkuse as main transcriptc.192T>G p.Phe64Leu missense_variant 3/12 XP_047287068.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
SNW1ENST00000261531.12 linkuse as main transcriptc.192T>G p.Phe64Leu missense_variant 3/141 NM_012245.3 ENSP00000261531.8 Q13573

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
30
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsFeb 11, 2022The c.192T>G (p.F64L) alteration is located in exon 3 (coding exon 3) of the SNW1 gene. This alteration results from a T to G substitution at nucleotide position 192, causing the phenylalanine (F) at amino acid position 64 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
1.0
BayesDel_addAF
Pathogenic
0.40
D
BayesDel_noAF
Pathogenic
0.34
CADD
Benign
21
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.73
D;D;.
Eigen
Benign
-0.16
Eigen_PC
Benign
-0.19
FATHMM_MKL
Uncertain
0.90
D
LIST_S2
Pathogenic
1.0
D;D;D
M_CAP
Uncertain
0.11
D
MetaRNN
Uncertain
0.74
D;D;D
MetaSVM
Uncertain
-0.096
T
MutationAssessor
Pathogenic
3.1
M;.;.
PrimateAI
Pathogenic
0.90
D
PROVEAN
Pathogenic
-5.0
D;D;D
REVEL
Pathogenic
0.78
Sift
Uncertain
0.0020
D;D;D
Sift4G
Uncertain
0.0040
D;D;D
Polyphen
0.24
B;D;.
Vest4
0.97
MutPred
0.69
Gain of catalytic residue at E66 (P = 3e-04);Gain of catalytic residue at E66 (P = 3e-04);Gain of catalytic residue at E66 (P = 3e-04);
MVP
0.87
MPC
0.87
ClinPred
0.99
D
GERP RS
0.86
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.92
gMVP
0.83

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr14-78217800; API